San Antonio Breast Cancer Symposium
sabcs.bsky.social
SABCS is the world's largest gathering of doctors, researchers and scientists sharing state-of-the-art information on experimental biology, etiology, prevention, diagnosis, and therapy for breast cancer and premalignant breast diseases. www.sabcs.org
👤 Joined on 20 November 2024
1222
Followers
6
Following
156
Total Posts
📜 Kullanıcı Geçmişi
- 20 Kas 2024, 19:23
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@sabcs.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
Mid-week into hot-off-the-press research results at the annual @sabcs.bsky.social Grateful to be sharing space and hugs with fellow advocates and colleagues 💗 #SABCS25
Show Post
@ncasasanta.bsky.social presents data at #SABCS25: In advanced #breastcancer, genomic profiling shows younger women more frequently have BRCA1/2, TP53, HRD, and PD-L1 alterations, while older women more often exhibit ESR1, PIK3CA, CDH1, and higher TMB. @sabcs.bsky.social @oncoalert.bsky.social
Show PostDr. Guannan Gong shares how an #AI-driven patient-matching system improved ID of eligible patients for #breastcancer trials + increased representation of under-enrolled groups. #SABCS25 @maryamlustberg.bsky.social @sabcs.bsky.social @oncoalert.bsky.social
Show PostNew research from Dr. Lajos Pusztai #SABCS25 shows RNA levels of ESR1, PGR closely match traditional estrogen receptor/progesterone receptor test results in #breastcancer. @foundationmedicine.bsky.social @sabcs.bsky.social @oncoalert.bsky.social
Show PostDr. Mariya Rozenblit highlights how C1D15 DiviTum® TKa levels can uncover early adherence issues or drug interactions during CDK4/6 inhibitor therapy. #SABCS25 Takeaway: DiviTum® TKa is a practical early biomarker to optimize breast cancer treatment outcomes. @sabcs.bsky.social
Show Post